Hemoglobinopathies by HPLC: A 3 Year Study of 106,277 Cases

  • Amruta Joshi Haematology, Metropolis healthcare Limited
  • Sanjay Gohil Haematology, Metropolis healthcare Limited
  • Bhavya Saxena Haematology, Metropolis healthcare Limited
  • Raj Jatale Medical Affairs Metropolis healthcare Limited
  • Kirti Chadha Medical Affairs Metropolis healthcare Limited
  • Reshma Haryan Haematology, Metropolis healthcare Limited
  • Priya Patil Haematology, Metropolis healthcare Limited
  • Milind Chanekar R&D, Metropolis healthcare Limited
Keywords: Hemoglobinopathies, Cation exchange high-performance liquid chromatography, thalassemia


Introduction: Hemoglobinopathies and thalassemias are the most common single gene disorders in the world. World Health Organization figures estimate that 5% of the world populations are carriers of a potentially pathological hemoglobin (Hb) gene. The general incidence of thalassemia trait and sickle cell anaemia in India varies between 3-17% and 1-44% respectively3 but because of consanguinity, caste and area endogamy, some communities show a very high incidence, making the disease a major public health problem in our country. Cation exchange high-performance liquid chromatography (CE-HPLC) is one of the best methods for screening, detection, and identification of various hemoglobinopathies. Material &Method: A retrospective study was carried out from period of 2017 to 2019 with 106277 cases evaluated with an aim to identify various hemoglobinopathies seen in Indian population by high-performance liquid chromatography. Cases outside Indian geographical location were excluded from the study Result: A total of 18,936(17.82%) cases with abnormal haemoglobin variants was reported in the study with 35 difference variants across India. Northeast India reported maximum abnormal hemoglobinopathies (50.16%). Beta Thalassemia Trait was the most common abnormal variant found.Such a high incidence emphasises premarital and prenatal screening for prevention of dangerous effects of hemoglobinopathies in the population. Conclusion: CE-HPLC should be used for early detection and proper management of these haemoglobinopathies. The most common hemoglobinopathy observed in our study was Beta thalassemia trait followed by Sickle cell trait and then sickle cell disease. It was also observed that Northeast India had maximum abnormal hemoglobinopathies.


WHO-EXECUTIVE BOARD EB118/5, 118 th Session Report by the Secretariat on Thalassaemia and other haemoglobinopathies: Prevalence of Haemoglobinopathies. 11 May 2006. p. 1-8

Balgir R. S. (1996). Genetic epidemiology of the three predominant abnormal hemoglobins in India. The Journal of the Association of Physicians of India, 44(1), 25–28.

Balgir, R.S. (2000). The burden of haemoglobinopathies in India and the challenges ahead. Current Science, 79, 1536-1547.

Balgir RS. (2002). Th e general burden of haemoglobinopathies with special reference to community health in India and the challenges ahead. India J Haemat Blood Transfusion.p.2-7

Bravo-Urquiola, M., Arends, A., Montilla, S., Velásquez, D., Garcìa, G., Alvarez, M., Guevara, J., & Castillo, O. (2004). Ventajas de la técnica de cromatografía líquida de alta presión (HPLC-CE) en el estudio de hemoglobinopatías en Venezuela [Advantages in the use of high performance liquid chromatography technique for screening hemoglobinopathies in Venezuela]. Investigacion clinica, 45(4), 309–315.

Mondal, S. K., & Mandal, S. (2016). Prevalence of thalassemia and hemoglobinopathy in eastern India: A 10-year high-performance liquid chromatography study of 119,336 cases. Asian journal of transfusion science, 10(1), 105–110.

Warghade, S., Britto, J., Haryan, R., Dalvi, T., Bendre, R.& Chheda, et al. (2018). Prevalence of hemoglobin variants and hemoglobinopathies using cation-exchange high-performance liquid chromatography in central reference laboratory of India: A report of 65779 cases. Journal of laboratory physicians, 10(1), 73–79.

Saha, S., Ghosh, S., Basu, K. et al. (2020). Prevalence of β-haemoglobinopathies in Eastern India and development of a novel formula for carrier detection. J Hematopathol 13, 159–164. https://doi.org/10.1007/s12308-020-00407-7

Shrivastav A, Patel U, Joshi JR, Kaur A and Agnihotri AS. (2013). Study of hemoglobinopathies and Hb variants in population of Western India using HPLC: A report of 7,000 cases. J Appl Hematol;4:104-9.

Chopra, G. S., Nair, V., Gupta, P. K., Mishra, D. K., Sharma, A., & Mathew, O. P. (2008). Spectrum of Haemoglobinopathies in a Tertiary Care Hospital of Armed Forces. Medical journal, Armed Forces India, 64(4), 311–314.

Cohen, P. T. W., Yates, A., Bellingham, A. J., & Huehns, E. R. (1973). Amino-acid substitution in the α1β1 intersubunit contact of haemoglobin-camden β131 (H9) gln→glu. Nature, 243(5408), 467-468.

Original Article